These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3546943)

  • 21. Testosterone differentially modulates gonadotropin subunit messenger ribonucleic acid responses to gonadotropin-releasing hormone pulse amplitude.
    Iliff-Sizemore SA; Ortolano GA; Haisenleder DJ; Dalkin AC; Krueger KA; Marshall JC
    Endocrinology; 1990 Dec; 127(6):2876-83. PubMed ID: 1701131
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GnRH action on luteal steroidogenesis during pregnancy.
    Sridaran R; Lee MA; Haynes L; Srivastava RK; Ghose M; Sridaran G; Smith CJ
    Steroids; 1999 Sep; 64(9):618-23. PubMed ID: 10503718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autoregulation of the gonadotropin-releasing hormone (GnRH) system during puberty: effects of antagonistic versus agonistic GnRH analogs in a female rat model.
    Roth C; Schricker M; Lakomek M; Strege A; Heiden I; Luft H; Munzel U; Wuttke W; Jarry H
    J Endocrinol; 2001 May; 169(2):361-71. PubMed ID: 11312152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypothalamus-pituitary-ovarian axis in cyclic rats lacking progesterone actions.
    Sánchez-Criado JE; Galiot F; Bellido C; Gonzalez D; Tébar M
    Biol Reprod; 1993 Apr; 48(4):916-25. PubMed ID: 8485257
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Failure of gonadotropin-releasing hormone (GnRH) pulses to increase luteinizing hormone beta messenger ribonucleic acid in GnRH-deficient female rats.
    Kerrigan JR; Dalkin AC; Haisenleder DJ; Yasin M; Marshall JC
    Endocrinology; 1993 Nov; 133(5):2071-9. PubMed ID: 8404655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gonadotropin-releasing hormone-agonist inhibits synthesis of nitric oxide and steroidogenesis by luteal cells in the pregnant rat.
    Yang H; Bhat GK; Wadley R; Wright KL; Chung BM; Whittaker JA; Dharmarajan AM; Sridaran R
    Biol Reprod; 2003 Jun; 68(6):2222-31. PubMed ID: 12606359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human ovarian steroid secretion in vivo: effects of GnRH agonist versus antagonist (cetrorelix).
    Garcia-Velasco JA; Isaza V; Vidal C; Landazábal A; Remohí J; Simón C; Pellicer A
    Hum Reprod; 2001 Dec; 16(12):2533-9. PubMed ID: 11726570
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH.
    Filicori M; Campaniello E; Michelacci L; Pareschi A; Ferrari P; Bolelli G; Flamigni C
    J Clin Endocrinol Metab; 1988 Feb; 66(2):327-33. PubMed ID: 3123511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Progesterone concentration, estradiol pretreatment, and dose of gonadotropin-releasing hormone affect gonadotropin-releasing hormone-mediated luteinizing hormone release in beef heifers.
    Dias FC; Colazo MG; Kastelic JP; Mapletoft RJ; Adams GP; Singh J
    Domest Anim Endocrinol; 2010 Oct; 39(3):155-62. PubMed ID: 20580523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progesterone stimulates luteinizing hormone secretion by acting directly on the pituitary.
    Couzinet B; Brailly S; Bouchard P; Schaison G
    J Clin Endocrinol Metab; 1992 Feb; 74(2):374-8. PubMed ID: 1730816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pituitary function is altered during the same cycle in women with polycystic ovary syndrome treated with continuous or cyclic oral contraceptives or a gonadotropin-releasing hormone agonist.
    Ruchhoft EA; Elkind-Hirsch KE; Malinak R
    Fertil Steril; 1996 Jul; 66(1):54-60. PubMed ID: 8752611
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of gonadotropin-releasing hormone agonist on human chorionic gonadotropin activity in granulosa cells of immature female rats.
    Tungmahasuk D; Fungbun N; Laoharatchatathanin T; Terashima R; Kurusu S; Kawaminami M
    J Reprod Dev; 2018 Apr; 64(2):129-134. PubMed ID: 29249775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of a gonadotropin releasing hormone analog on an experimental ovarian tumor: direct and indirect actions.
    Lux-Lantos VA; Thyssen SM; Chamson A; Libertun C
    Life Sci; 1995; 57(3):291-300. PubMed ID: 7596232
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
    Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The ovarian secretion of androstenedione and oestradiol during late pregnancy and the early postpartum period in sheep with an autotransplanted ovary.
    Scaramuzzi RJ; Cognié Y; Downing JA
    Reprod Nutr Dev; 1996; 36(5):531-43. PubMed ID: 8987105
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone.
    Eagleson CA; Gingrich MB; Pastor CL; Arora TK; Burt CM; Evans WS; Marshall JC
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4047-52. PubMed ID: 11095431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of the estradiol-induced luteinizing hormone surge by progesterone or antiestrogens: effects on pituitary gonadotropin-releasing hormone receptors.
    Attardi B; Happe HK
    Endocrinology; 1986 Jul; 119(1):274-83. PubMed ID: 3013589
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ovarian 17-hydroxyprogesterone hyperresponsiveness to gonadotropin-releasing hormone (GnRH) agonist challenge in women with polycystic ovary syndrome is not mediated by luteinizing hormone hypersecretion: evidence from GnRH agonist and human chorionic gonadotropin stimulation testing.
    Ibañez L; Hall JE; Potau N; Carrascosa A; Prat N; Taylor AE
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4103-7. PubMed ID: 8923867
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of sex steroids on pituitary responsiveness to gonadotropin releasing hormone.
    Eshkol A; Lunenfeld B; Insler V
    J Steroid Biochem; 1975 Jun; 6(6):1061-6. PubMed ID: 1100906
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Levels of follicle-stimulating hormone, luteinizing hormone, oestradiol-17 beta and progesterone, and follicular growth in the pseudopregnant rat.
    Welschen R; Osman P; Dullaart J; de Greef WJ; Uilenbroek JT; de Jong FH
    J Endocrinol; 1975 Jan; 64(1):37-47. PubMed ID: 1167896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.